From this study and from an additional meta-analysis assessing 31 single nucleotide polymorphisms present in the IGF1 and IGFBP3 genes, the authors concluded that neither circulating IGFBP-3 or IGF-I nor the corresponding genes were causative for the development of CAD in human populations. The gene discussed is IGFBP3; the disease is coronary artery disorder.